Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for HLSQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 11.16M
March 31, 2026 2.419M
December 31, 2025 -1.302M
September 30, 2025 10.49M
June 30, 2025 19.16M
March 31, 2025 24.50M
December 31, 2024 24.15M
September 30, 2024 37.90M
June 30, 2024 27.42M
March 31, 2024 22.88M
December 31, 2023 3.081M
September 30, 2023 8.154M
June 30, 2023 15.86M
March 31, 2023 16.15M
December 31, 2022 21.04M
September 30, 2022 26.56M
Date Value
June 30, 2022 32.74M
March 31, 2022 40.02M
December 31, 2021 47.54M
September 30, 2021 53.43M
June 30, 2021 48.59M
March 31, 2021 53.95M
December 31, 2020 57.47M
September 30, 2020 65.84M
June 30, 2020 73.52M
March 31, 2020 79.00M
December 31, 2019 84.46M
September 30, 2019 34.26M
June 30, 2019
March 31, 2019 70.69M
December 31, 2018 42.80M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -199.08M
Amgen, Inc. 11.69B
Anika Therapeutics, Inc. 137.28M
BioCryst Pharmaceuticals, Inc. -454.29M
Imunon, Inc. 4.189M

Shareholders Equity (Quarterly) Related Metrics